Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation

Abstract Medication-Assisted Treatment (MAT) provides an opportunity to address opioid addiction among justice-involved individuals, an often difficult to reach population. This potential has been increasingly recognized by agencies, policymakers and pharmaceutical companies. The result has been a m...

Full description

Bibliographic Details
Main Authors: Jordan M. Hyatt, Philipp P. Lobmaier
Format: Article
Language:English
Published: BMC 2020-03-01
Series:Health & Justice
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40352-020-0106-9
id doaj-984323bde8bf45649f1bc4731bcab1e3
record_format Article
spelling doaj-984323bde8bf45649f1bc4731bcab1e32020-11-25T02:51:12ZengBMCHealth & Justice2194-78992020-03-018111010.1186/s40352-020-0106-9Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participationJordan M. Hyatt0Philipp P. Lobmaier1Department of Criminology and Justice Studies, Drexel UniversityNorwegian Centre for Addiction Research, University of OsloAbstract Medication-Assisted Treatment (MAT) provides an opportunity to address opioid addiction among justice-involved individuals, an often difficult to reach population. This potential has been increasingly recognized by agencies, policymakers and pharmaceutical companies. The result has been a marked increase in the number of drug courts, prisons and agencies in which MAT, notably with long-acting injectable medications, is offered. While this is a positive development, ensuring that vulnerable individuals are in a position voluntarily participation within the complex criminal justice environment is necessary. The unequal authority and agency inherent in the nature of these environments should be recognized. Therefore, rigorous protections, mirroring the goals of the consent processes required for medical or sociobehavorial research, should be employed when MAT is offered to protect individual autonomy.http://link.springer.com/article/10.1186/s40352-020-0106-9Medication-assisted treatment (MAT)Opioid abuseCorrectionsDrug addictionInformed consentCoercion
collection DOAJ
language English
format Article
sources DOAJ
author Jordan M. Hyatt
Philipp P. Lobmaier
spellingShingle Jordan M. Hyatt
Philipp P. Lobmaier
Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation
Health & Justice
Medication-assisted treatment (MAT)
Opioid abuse
Corrections
Drug addiction
Informed consent
Coercion
author_facet Jordan M. Hyatt
Philipp P. Lobmaier
author_sort Jordan M. Hyatt
title Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation
title_short Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation
title_full Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation
title_fullStr Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation
title_full_unstemmed Medication assisted treatment (MAT) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation
title_sort medication assisted treatment (mat) in criminal justice settings as a double-edged sword: balancing novel addiction treatments and voluntary participation
publisher BMC
series Health & Justice
issn 2194-7899
publishDate 2020-03-01
description Abstract Medication-Assisted Treatment (MAT) provides an opportunity to address opioid addiction among justice-involved individuals, an often difficult to reach population. This potential has been increasingly recognized by agencies, policymakers and pharmaceutical companies. The result has been a marked increase in the number of drug courts, prisons and agencies in which MAT, notably with long-acting injectable medications, is offered. While this is a positive development, ensuring that vulnerable individuals are in a position voluntarily participation within the complex criminal justice environment is necessary. The unequal authority and agency inherent in the nature of these environments should be recognized. Therefore, rigorous protections, mirroring the goals of the consent processes required for medical or sociobehavorial research, should be employed when MAT is offered to protect individual autonomy.
topic Medication-assisted treatment (MAT)
Opioid abuse
Corrections
Drug addiction
Informed consent
Coercion
url http://link.springer.com/article/10.1186/s40352-020-0106-9
work_keys_str_mv AT jordanmhyatt medicationassistedtreatmentmatincriminaljusticesettingsasadoubleedgedswordbalancingnoveladdictiontreatmentsandvoluntaryparticipation
AT philippplobmaier medicationassistedtreatmentmatincriminaljusticesettingsasadoubleedgedswordbalancingnoveladdictiontreatmentsandvoluntaryparticipation
_version_ 1724735724921552896